HomeCompareCBLUF vs PFE

CBLUF vs PFE: Dividend Comparison 2026

CBLUF yields 4.41% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBLUF wins by $885.9K in total portfolio value
10 years
CBLUF
CBLUF
● Live price
4.41%
Share price
$0.38
Annual div
$0.02
5Y div CAGR
54.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$936.9K
Annual income
$592,012.65
Full CBLUF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — CBLUF vs PFE

📍 CBLUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBLUFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBLUF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBLUF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBLUF
Annual income on $10K today (after 15% tax)
$375.14/yr
After 10yr DRIP, annual income (after tax)
$503,210.75/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, CBLUF beats the other by $480,081.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBLUF + PFE for your $10,000?

CBLUF: 50%PFE: 50%
100% PFE50/50100% CBLUF
Portfolio after 10yr
$494.0K
Annual income
$309,611.59/yr
Blended yield
62.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CBLUF
No analyst data
Altman Z
3.3
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBLUF buys
0
PFE buys
0
No recent congressional trades found for CBLUF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBLUFPFE
Forward yield4.41%6.20%
Annual dividend / share$0.02$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR54.3%13.2%
Portfolio after 10y$936.9K$51.1K
Annual income after 10y$592,012.65$27,210.54
Total dividends collected$879.9K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CBLUF vs PFE ($10,000, DRIP)

YearCBLUF PortfolioCBLUF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,381$680.99$9,161$701.38+$2.2KCBLUF
2$13,295$1,117.65$8,610$859.79+$4.7KCBLUF
3$16,109$1,882.81$8,366$1,081.25+$7.7KCBLUF
4$20,526$3,289.68$8,483$1,405.66+$12.0KCBLUF
5$28,008$6,044.76$9,084$1,907.24+$18.9KCBLUF
6$41,862$11,894.10$10,418$2,732.78+$31.4KCBLUF
7$70,429$25,636.58$13,007$4,193.56+$57.4KCBLUF
8$137,557$62,197.37$18,010$7,005.87+$119.5KCBLUF
9$322,365$175,179.28$28,216$12,979.89+$294.1KCBLUF
10$936,943$592,012.65$51,081$27,210.54+$885.9KCBLUF

CBLUF vs PFE: Complete Analysis 2026

CBLUFStock

China BlueChemical Ltd., together with its subsidiaries, develops, manufactures, and sells mineral fertilizers and chemical products in the People's Republic of China and internationally. The company operates through Urea, Phosphorus and Compound Fertiliser, Methanol, and Others segments. It offers urea; mono-ammonium phosphate, di-ammonium phosphate, and compound fertilizers; methanol; and bulk blending fertilizers, and polyformaldehyde and woven plastic bags. The company is also involved in the trading of fertilizers and chemicals; mining, processing, manufacturing, and selling of phosphate; port operations; and provision of preparatory work for methanol and dimethyl-ether projects. In addition, it offers transportation and overseas shipping services; and manufactures and sells acrylonitrile and methyl methacrylate. The company was formerly known as CNOOC Chemical Limited and changed its name to China BlueChemical Ltd. in April 2006. The company was founded in 2000 and is headquartered in Beijing, the People's Republic of China. China BlueChemical Ltd. is a subsidiary of China National Offshore Oil Corporation.

Full CBLUF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CBLUF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBLUF vs SCHDCBLUF vs JEPICBLUF vs OCBLUF vs KOCBLUF vs MAINCBLUF vs JNJCBLUF vs MRKCBLUF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.